Novo Nordisk Investor
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases. Its main offerings include pioneering scientific breakthroughs and expanding access to their medicines, with the ultimate goal of preventing and curing disease.
Headquarters:
Bagsværd,Hovedstaden,Denmark,Europe
Industry:
Regenerative Medicine
Number Of Exists:
4
Investor Type:
Private Equity Funds
Founded Date:
1923-01-01
Funding Status:
public